chariva 0,03 mg/2 mg filmsko obložene tablete
gedeon richter plc. - etinilestradiol; klormadinonacetat - filmsko obložena tableta - etinilestradiol 0,03 mg / 1 tableta klormadinonacetat2 mg / 1 tableta; klormadinonacetat 2 mg / 1 tableta - klormadinon in etinilestradiol
chariva 0,03 mg/2 mg filmsko obložene tablete
gedeon richter plc. - etinilestradiol; klormadinonacetat - filmsko obložena tableta - etinilestradiol 0,03 mg / 1 tableta klormadinonacetat2 mg / 1 tableta; klormadinonacetat 2 mg / 1 tableta - klormadinon in etinilestradiol
ortanol 40 mg prašek za raztopino za infundiranje
prašek za raztopino za infundiranje - omeprazol
sumamed 200 mg/5 ml prašek za peroralno suspenzijo
prašek za peroralno suspenzijo - azitromicin
vankomicin hospira 500 mg prašek za koncentrat za raztopino za infundiranje
hospira uk ltd. - vankomicin - prašek za koncentrat za raztopino za infundiranje - vankomicin 500 mg / 1 viala - vankomicin
vankomicin hospira 1000 mg prašek za koncentrat za raztopino za infundiranje
hospira uk ltd. - vankomicin - prašek za koncentrat za raztopino za infundiranje - vankomicin 1000 mg / 1 viala - vankomicin
hexacima
sanofi pasteur - hepatitis b surface antigen, diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens pertussis toxoid filamentous haemagglutinin, poliovirus (inactivated) type 1 (mahoney) type 2 (mef-1) type 3 (saukett), haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines, bacterial and viral vaccines, combined - hexacima (dtap-ipv-hb-hib) je indicirano za osnovno in obnovitveno cepljenje dojenčkov in malčkov iz šestih tednih starosti proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b (hib). uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
abakavir/lamivudin sandoz 600 mg/300 mg filmsko obložene tablete
sandoz d.d. - abakavir, lamivudin - filmsko obložena tableta - abakavir 600 mg / 1 tableta; lamivudin 300 mg / 1 tableta - lamivudin in abakavir
abakavir/lamivudin sandoz 600 mg/300 mg filmsko obložene tablete
sandoz d.d. - abakavir, lamivudin - filmsko obložena tableta - abakavir 600 mg / 1 tableta; lamivudin 300 mg / 1 tableta - lamivudin in abakavir